Compare K & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | K | DXCM |
|---|---|---|
| Founded | 1906 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1B | 31.7B |
| IPO Year | N/A | 2005 |
| Metric | K | DXCM |
|---|---|---|
| Price | $83.12 | $65.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 21 |
| Target Price | $83.50 | ★ $87.81 |
| AVG Volume (30 Days) | 2.6M | ★ 5.9M |
| Earning Date | 10-30-2025 | 10-30-2025 |
| Dividend Yield | ★ 2.79% | N/A |
| EPS Growth | ★ 25.78 | 7.75 |
| EPS | ★ 3.66 | 1.80 |
| Revenue | ★ $12,670,000,000.00 | $4,515,900,000.00 |
| Revenue This Year | $2.08 | $17.41 |
| Revenue Next Year | $2.34 | $12.78 |
| P/E Ratio | ★ $22.72 | $36.45 |
| Revenue Growth | N/A | ★ 14.21 |
| 52 Week Low | $76.48 | $54.11 |
| 52 Week High | $83.65 | $93.25 |
| Indicator | K | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 49.46 | 60.15 |
| Support Level | $83.05 | $61.08 |
| Resistance Level | $83.44 | $65.32 |
| Average True Range (ATR) | 0.15 | 1.88 |
| MACD | -0.10 | 0.92 |
| Stochastic Oscillator | 10.83 | 86.86 |
Following its split from the North American cereal business in October 2023, Kellanova (previously the global snacking arm of Kellogg) has operated as a leading global manufacturer and marketer of salty snacks, snack bars, frozen breakfast fare, meat alternatives, and other packaged foods. Its offerings are manufactured in around 20 countries and marketed in over 180. Its product mix includes well-known brands such as Pringles, Cheez-It, Rice Krispies Treats, Pop-Tarts, Eggo, Nutri-Grain, and Morningstar Farms. Sales beyond its home turf account for about two thirds of Kellanova's consolidated sales base. Mars is slated to acquire the recently independent business in a nearly $36 billion deal.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.